Rapid Quantification of Gabapentin, Pregabalin, and Vigabatrin in Human Serum by Ultraperformance Liquid Chromatography With Mass-Spectrometric Detection
Gabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to samples from subjects participating in a pharmacokinetic study of GBP. Sample pretreatment consisted of adding 20 μL of trichloroacetic acid (...
Saved in:
Published in: | Therapeutic drug monitoring Vol. 35; no. 1; pp. 48 - 53 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hagerstown, MD
Lippincott Williams & Wilkins
01-02-2013
Lippincott Williams & Wilkins Ovid Technologies |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Gabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to samples from subjects participating in a pharmacokinetic study of GBP.
Sample pretreatment consisted of adding 20 μL of trichloroacetic acid (30%; vol/vol) and 200 μL of GBP-d4 in acetonitrile as an internal standard to 20 μL of serum. Chromatographic separation was performed on an Acquity separation module using a Kinetex RP18 column. The aqueous and organic mobile phases were 2 mM ammonium acetate supplemented with 0.1% formic acid in water and acetonitrile, respectively. The detection by a tandem quadrupole mass spectrometer, operating in the positive mode using multiple reaction monitoring, was completed within 2 minutes.
The method was linear over the range of 0.03-25 mg/L for GBP, 0.03-25 mg/L for PRG, and 0.06-50 mg/L for VIG. The between- and within-run accuracies ranged from 90% to 107%. The between- and within-run imprecisions of the method were <10%. Stability data show no significant decrease of the analytes. A relative matrix effect of -1%, 0.2%, and -5% was determined for GBP, PRG, and VIG, respectively.
A simple and sensitive ultraperformance liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of GBP, PRG, and VIG in human serum. The reported method provided the necessary linearity, precision, and accuracy to allow the determination of GBP, PRG, and VIG for therapeutic drug monitoring and clinical research purposes. |
---|---|
AbstractList | BACKGROUNDGabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to samples from subjects participating in a pharmacokinetic study of GBP.METHODSSample pretreatment consisted of adding 20 μL of trichloroacetic acid (30%; vol/vol) and 200 μL of GBP-d4 in acetonitrile as an internal standard to 20 μL of serum. Chromatographic separation was performed on an Acquity separation module using a Kinetex RP18 column. The aqueous and organic mobile phases were 2 mM ammonium acetate supplemented with 0.1% formic acid in water and acetonitrile, respectively. The detection by a tandem quadrupole mass spectrometer, operating in the positive mode using multiple reaction monitoring, was completed within 2 minutes.RESULTSThe method was linear over the range of 0.03-25 mg/L for GBP, 0.03-25 mg/L for PRG, and 0.06-50 mg/L for VIG. The between- and within-run accuracies ranged from 90% to 107%. The between- and within-run imprecisions of the method were <10%. Stability data show no significant decrease of the analytes. A relative matrix effect of -1%, 0.2%, and -5% was determined for GBP, PRG, and VIG, respectively.CONCLUSIONSA simple and sensitive ultraperformance liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of GBP, PRG, and VIG in human serum. The reported method provided the necessary linearity, precision, and accuracy to allow the determination of GBP, PRG, and VIG for therapeutic drug monitoring and clinical research purposes. Gabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to samples from subjects participating in a pharmacokinetic study of GBP. Sample pretreatment consisted of adding 20 μL of trichloroacetic acid (30%; vol/vol) and 200 μL of GBP-d4 in acetonitrile as an internal standard to 20 μL of serum. Chromatographic separation was performed on an Acquity separation module using a Kinetex RP18 column. The aqueous and organic mobile phases were 2 mM ammonium acetate supplemented with 0.1% formic acid in water and acetonitrile, respectively. The detection by a tandem quadrupole mass spectrometer, operating in the positive mode using multiple reaction monitoring, was completed within 2 minutes. The method was linear over the range of 0.03-25 mg/L for GBP, 0.03-25 mg/L for PRG, and 0.06-50 mg/L for VIG. The between- and within-run accuracies ranged from 90% to 107%. The between- and within-run imprecisions of the method were <10%. Stability data show no significant decrease of the analytes. A relative matrix effect of -1%, 0.2%, and -5% was determined for GBP, PRG, and VIG, respectively. A simple and sensitive ultraperformance liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of GBP, PRG, and VIG in human serum. The reported method provided the necessary linearity, precision, and accuracy to allow the determination of GBP, PRG, and VIG for therapeutic drug monitoring and clinical research purposes. Gabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to samples from subjects participating in a pharmacokinetic study of GBP. Sample pretreatment consisted of adding 20 ...L of trichloroacetic acid (30%; vol/vol) and 200 ..L of GBP-d4 in acetonitrile as an internal standard to 20 ...L of serum. Chromatographic separation was performed on an Acquity separation module using a Kinetex RP18 column. The aqueous and organic mobile phases were 2 mM ammonium acetate supplemented with 0.1% formic acid in water and acetonitrile, respectively. The detection by a tandem quadrupole mass spectrometer, operating in the positive mode using multiple reaction monitoring, was completed within 2 minutes. The method was linear over the range of 0.03-25 mg/L for GBP, 0.03-25 mg/L for PRG, and 0.06-50 mg/L for VIG. The between- and within-run accuracies ranged from 90% to 107%. The between- and within-run imprecisions of the method were <10%. Stability data show no significant decrease of the analytes. A relative matrix effect of -1%, 0.2%, and -5% was determined for GBP, PRG, and VIG, respectively. A simple and sensitive ultraperformance liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of GBP, PRG, and VIG in human serum. The reported method provided the necessary linearity, precision, and accuracy to allow the determination of GBP, PRG, and VIG for therapeutic drug monitoring and clinical research purposes. (ProQuest: ... denotes formulae/symbols omitted.) |
Author | CHAHBOUNI, Abdel SINJEWEL, Arno VOS, René M VELDKAMP, Agnes I SWART, Eleanora L WILHELM, Abraham J DEN BURGER, Jeroen C. G |
Author_xml | – sequence: 1 givenname: Abdel surname: CHAHBOUNI fullname: CHAHBOUNI, Abdel organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands – sequence: 2 givenname: Arno surname: SINJEWEL fullname: SINJEWEL, Arno organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands – sequence: 3 givenname: Jeroen C. G surname: DEN BURGER fullname: DEN BURGER, Jeroen C. G organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands – sequence: 4 givenname: René M surname: VOS fullname: VOS, René M organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands – sequence: 5 givenname: Abraham J surname: WILHELM fullname: WILHELM, Abraham J organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands – sequence: 6 givenname: Agnes I surname: VELDKAMP fullname: VELDKAMP, Agnes I organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands – sequence: 7 givenname: Eleanora L surname: SWART fullname: SWART, Eleanora L organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27062519$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23188183$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkd1q3DAQhUVJaTZp36AUQSn0Ik4ly5Ksy7BpksKW_iRpL40sj7MKtuRI8sU-St82Mtm2EBBIM_OdmUHnCB047wCht5ScUqLkp4ub81PSEsqA0bqUsq4NeYFWlDNRMKGqA7QiVLCiYlwcoqMY7wmhVU3IK3RYZklNa7ZCf37qyXb4x6xdsr01OlnvsO_xpW71BDnpTvD3AHc5HJa3dh3-ZZcwBetwPlfzqB2-hjCPuN3h2yGFrAy9DzlvAG_sw5xHrLfBjzr5u1zd7vBvm7b4q46xuJ7ApFyD3NDgc0g5zEu8Ri97PUR4s7-P0e3F55v1VbH5dvllfbYpDBM8FSBEX_HSSCNIBb0SUnUd14KLEninupIbIlvR5QoY0iqpe2MYMS1IMFIpdow-PvWdgn-YIaZmtNHAMGgHfo4NLSXjVaXqBX3_DL33c3B5u4UiXJaqrjNVPVEm-BgD9M0U7KjDrqGkWaxrsnXNc-uy7N2--dyO0P0T_fUqAx_2gI5GD33Iv2vjf04SUXKq2CMP86a1 |
CODEN | TDMODV |
CitedBy_id | crossref_primary_10_1097_FTD_0000000000000516 crossref_primary_10_2174_1573412914666171228160833 crossref_primary_10_1177_0003702817716181 crossref_primary_10_1016_j_jpba_2020_113172 crossref_primary_10_1093_jat_bku004 crossref_primary_10_1016_j_chroma_2016_08_057 crossref_primary_10_1080_10408347_2020_1855411 crossref_primary_10_1080_10408347_2021_1916733 crossref_primary_10_1016_j_toxac_2020_10_019 crossref_primary_10_1002_cpt_1353 crossref_primary_10_1016_j_saa_2020_119021 crossref_primary_10_1093_jat_bku010 crossref_primary_10_1097_FTD_0000000000000325 crossref_primary_10_3390_separations10040234 crossref_primary_10_1002_bmc_5023 crossref_primary_10_1007_s40262_014_0177_7 crossref_primary_10_3390_separations8020021 crossref_primary_10_1016_j_seizure_2017_09_015 crossref_primary_10_1093_chromsci_bmab031 crossref_primary_10_1002_dta_1733 crossref_primary_10_1038_clpt_2013_108 crossref_primary_10_1016_j_chroma_2017_04_049 crossref_primary_10_1016_j_jchromb_2014_05_037 crossref_primary_10_1016_j_jpba_2016_09_036 crossref_primary_10_1093_jat_bkt081 |
Cites_doi | 10.1365/s10337-007-0440-2 10.1021/ac020361s 10.1016/j.seizure.2005.11.005 10.1081/JLC-100101455 10.1016/j.jpba.2010.02.036 10.1097/01.ftd.0000158874.54100.1a 10.1016/j.jchromb.2005.11.009 10.1016/j.cell.2009.09.025 10.1093/chromsci/47.10.868 10.1111/j.1528-1167.2008.01561.x 10.1016/S0074-7696(02)13011-7 10.1016/S1570-0232(04)00662-2 10.1023/A:1007669411738 10.1016/j.clinthera.2007.01.013 10.1016/S0378-4347(97)00521-5 10.1111/j.1365-2710.2010.01243.x 10.1002/jssc.200800461 |
ContentType | Journal Article |
Copyright | 2014 INIST-CNRS Copyright Lippincott Williams & Wilkins Feb 2013 |
Copyright_xml | – notice: 2014 INIST-CNRS – notice: Copyright Lippincott Williams & Wilkins Feb 2013 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION K9. 7X8 |
DOI | 10.1097/FTD.0b013e31827788c0 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1536-3694 |
EndPage | 53 |
ExternalDocumentID | 2868318601 10_1097_FTD_0b013e31827788c0 23188183 27062519 |
Genre | Journal Article Feature |
GroupedDBID | --- .-D .GJ .Z2 0R~ 123 1CY 3O- 4Q1 4Q2 4Q3 53G 5RE 5VS 71W 8L- 8W4 AAHPQ AAMTA AAPBV AARTV AAYEP ABASU ABBUW ABDIG ABFLS ABOCM ABXVJ ABZAD ACDDN ACEWG ACGFO ACGFS ACWDW ACWRI ACXNZ ADFPA ADNKB AE3 AE6 AENEX AFDTB AFFNX AHMBA AHVBC AJIOK AJNYG ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AWKKM BQLVK BS7 C45 CS3 DIWNM DU5 DUNZO E.X EBS EJD EX3 F2K F2L F5P FL- GQDEL H0~ HZ~ IKREB IN~ IPNFZ IQODW J5H JK3 JK8 K8S KD2 KMI L-C N9A N~M O9- OAG OAH OCUKA ODA OJAPA OL1 OLG OLV OLW OLZ OPC OPUJH ORVUJ OUVQU OVD OVDNE OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQEST PQQKQ R58 RIG RLZ S4R S4S TEORI TSPGW V2I VVN W3M WOQ WOW X3V X3W XXN XYM YFH YOC ZFV ZGI ZXP ZY1 ZZMQN AAAAV AAIQE AASCR ABJNI ABVCZ ACILI ACXJB ADGGA ADHPY AEETU AHQNM AINUH AJNWD AJZMW AMNEI AOHHW CGR CUY CVF ECM EEVPB EIF FCALG GNXGY HLJTE NPM AAYXX CITATION K9. 7X8 |
ID | FETCH-LOGICAL-c365t-e66f452c7c604ef9679dd5a6562e5d9d25c07b6df96ec0b97afcc30cbe7ec7993 |
ISSN | 0163-4356 |
IngestDate | Fri Aug 16 07:50:18 EDT 2024 Thu Oct 10 17:25:03 EDT 2024 Fri Aug 23 00:19:06 EDT 2024 Sat Sep 28 08:00:10 EDT 2024 Thu Nov 24 18:30:56 EST 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Human Biological fluid LC―MS 4-Aminobutyrate transaminase Gabapentin Enzyme Transferases Enzyme inhibitor HPLC chromatography Exploration Anticonvulsant Liquid chromatography Pregabalin Analgesic Vigabatrin Transaminases Serum Diagnosis Detection Mass spectrometry |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c365t-e66f452c7c604ef9679dd5a6562e5d9d25c07b6df96ec0b97afcc30cbe7ec7993 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 23188183 |
PQID | 1270572988 |
PQPubID | 31802 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1273544989 proquest_journals_1270572988 crossref_primary_10_1097_FTD_0b013e31827788c0 pubmed_primary_23188183 pascalfrancis_primary_27062519 |
PublicationCentury | 2000 |
PublicationDate | 2013-02-01 |
PublicationDateYYYYMMDD | 2013-02-01 |
PublicationDate_xml | – month: 02 year: 2013 text: 2013-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States – name: New York |
PublicationTitle | Therapeutic drug monitoring |
PublicationTitleAlternate | Ther Drug Monit |
PublicationYear | 2013 |
Publisher | Lippincott Williams & Wilkins Lippincott Williams & Wilkins Ovid Technologies |
Publisher_xml | – name: Lippincott Williams & Wilkins – name: Lippincott Williams & Wilkins Ovid Technologies |
References | Berry (R10-4-20210129) 2005; 27 Rosing (R16-4-20210129) 2000; 23 Eroglu (R3-4-20210129) 2009; 139 Patsalos (R21-4-20210129) 2008; 49 Mandal (R12-4-20210129) 2008; 67 Watanabe (R2-4-20210129) 2002; 213 Wad (R8-4-20210129) 1998; 705 Tassone (R4-4-20210129) 2007; 29 Hamandi (R5-4-20210129) 2006; 15 Matuszewski (R19-4-20210129) 2003; 75 Oertel (R14-4-20210129) 2009; 32 Wattananat (R13-4-20210129) 2009; 47 Mercolini (R7-4-20210129) 2010; 53 Matuszewski (R20-4-20210129) 2006; 830 Vermeij (R11-4-20210129) 2004; 810 Shah (R15-4-20210129) 2000; 12 Yagi (R9-4-20210129) 2012; 37 |
References_xml | – volume: 67 start-page: 237 year: 2008 ident: R12-4-20210129 article-title: . Determination of pregablin in human plasma using LC-MS-MS. publication-title: Chromatographia doi: 10.1365/s10337-007-0440-2 contributor: fullname: Mandal – volume: 75 start-page: 3019 year: 2003 ident: R19-4-20210129 article-title: Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MSMS. publication-title: Anal Chem doi: 10.1021/ac020361s contributor: fullname: Matuszewski – volume: 15 start-page: 73 year: 2006 ident: R5-4-20210129 article-title: Pregabalin: a new antiepileptic drug for refractory epilepsy. publication-title: Seizure doi: 10.1016/j.seizure.2005.11.005 contributor: fullname: Hamandi – volume: 23 start-page: 329 year: 2000 ident: R16-4-20210129 article-title: . Bioanalytical liquid chromatography method validation. A review of current practices and procedures. publication-title: J Liq Chrom Rel Technol doi: 10.1081/JLC-100101455 contributor: fullname: Rosing – volume: 53 start-page: 62 year: 2010 ident: R7-4-20210129 article-title: . Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma. publication-title: J Pharm Biomed Anal doi: 10.1016/j.jpba.2010.02.036 contributor: fullname: Mercolini – volume: 27 start-page: 451 year: 2005 ident: R10-4-20210129 article-title: Analysis of pregabalin at therapeutic concentrations in human plasmaserum by reversed-phase HPLC. publication-title: Ther Drug Monit doi: 10.1097/01.ftd.0000158874.54100.1a contributor: fullname: Berry – volume: 830 start-page: 293 year: 2006 ident: R20-4-20210129 article-title: Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. publication-title: J Chromatogr B Analyt Technol Biomed Life Sci doi: 10.1016/j.jchromb.2005.11.009 contributor: fullname: Matuszewski – volume: 139 start-page: 380 year: 2009 ident: R3-4-20210129 article-title: . Gabapentin receptor 2-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. publication-title: Cell doi: 10.1016/j.cell.2009.09.025 contributor: fullname: Eroglu – volume: 47 start-page: 868 year: 2009 ident: R13-4-20210129 article-title: Validated LC-MS-MS method for the determination of gabapentin in human plasma: application to a bioequivalence study. publication-title: J Chromatogr Sci doi: 10.1093/chromsci/47.10.868 contributor: fullname: Wattananat – volume: 49 start-page: 1239 year: 2008 ident: R21-4-20210129 article-title: . Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. publication-title: Epilepsia doi: 10.1111/j.1528-1167.2008.01561.x contributor: fullname: Patsalos – volume: 213 start-page: 1 year: 2002 ident: R2-4-20210129 article-title: . GABA and GABA receptors in the central nervous system and other organs. publication-title: Int Rev Cytol doi: 10.1016/S0074-7696(02)13011-7 contributor: fullname: Watanabe – volume: 810 start-page: 297 year: 2004 ident: R11-4-20210129 article-title: Simultaneous high-performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o-phthaldialdehyde and fluorescence detection. publication-title: J Chromatogr B Anal Technol Biomed Life Sci doi: 10.1016/S1570-0232(04)00662-2 contributor: fullname: Vermeij – volume: 12 start-page: 1551 year: 2000 ident: R15-4-20210129 article-title: . Bioanalytical method validationa revisit with a decade of progress. publication-title: Pharm Res doi: 10.1023/A:1007669411738 contributor: fullname: Shah – volume: 29 start-page: 26 year: 2007 ident: R4-4-20210129 article-title: . Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. publication-title: Clin Ther doi: 10.1016/j.clinthera.2007.01.013 contributor: fullname: Tassone – volume: 705 start-page: 154 year: 1998 ident: R8-4-20210129 article-title: Sensitive high-performance liquid chromatographic method with fluorometric detection for the simultaneous determination of gabapentin and vigabatrin in serum and urine. publication-title: J Chromatogr B Biomed Sci Appl doi: 10.1016/S0378-4347(97)00521-5 contributor: fullname: Wad – volume: 37 start-page: 89 year: 2012 ident: R9-4-20210129 article-title: . Rapid and validated fluorometric HPLC method for determination of gabapentin in human plasma and urine for clinical application. publication-title: J Clin Pharm Ther doi: 10.1111/j.1365-2710.2010.01243.x contributor: fullname: Yagi – volume: 32 start-page: 238 year: 2009 ident: R14-4-20210129 article-title: . Simultaneous determination of three anticonvulsants using hydrophilic interaction LC-MS. publication-title: J Sep Sci doi: 10.1002/jssc.200800461 contributor: fullname: Oertel |
SSID | ssj0014800 |
Score | 2.2139747 |
Snippet | Gabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to... BACKGROUNDGabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 48 |
SubjectTerms | Amines - blood Anticonvulsants - blood Biological and medical sciences Blood Chemical Analysis - methods Chromatography Chromatography, High Pressure Liquid - methods Convulsions & seizures Cyclohexanecarboxylic Acids - blood Drug Stability Drug use Epilepsy gamma-Aminobutyric Acid - analogs & derivatives gamma-Aminobutyric Acid - blood Humans Mass spectrometry Medical sciences Pharmacology Pharmacology. Drug treatments Pregabalin Tandem Mass Spectrometry - methods Vigabatrin - blood |
Title | Rapid Quantification of Gabapentin, Pregabalin, and Vigabatrin in Human Serum by Ultraperformance Liquid Chromatography With Mass-Spectrometric Detection |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23188183 https://www.proquest.com/docview/1270572988 https://search.proquest.com/docview/1273544989 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZ2eUFCiDuFMRkJ7aWN8HJxnMeytTCpbNXWTXuLEtvZgra0pAmoP4V_y7Gdy7INBA9IVVQ5TZr2fPl8fPKdcxB67yeUuY5Q7dsJt9wYNiwhxJK2lziMRoRyHbo48Q_P2f7IHa2t13302rH_amkYA1urzNl_sHZzUhiA92Bz2ILVYftXdj-OFqlQWk2jAmo8wk9RHC2UNEjTzDSXFzBQdWtXwfOzVA0Ueaqljya2D0RSXisH9fSqUFlabY7BJP1Wwteo0rrg8lZlr4Fiisv-F3DHLdXWvlCVEFQDACC1Qiu-spuu8KzN_OqLvLzoX2t6yeu51GgOLmOgI604GMZCNnKQkzT7Kn9UCoM8mzcyoj7waP-jzvU24p18DgNNKPjMqAqPgWy1QqAKBldhD9WCoiMhua98hQ57pFdaW3T0Hf6E5ulErcesYqjUscBLrCpw17xPLYeafsv1xGDqqHRuAMPypjboncnHFDUez_bb6LLt-4xx0k62tcDg8Cgcn04m4Wx0Puvu1b6FzSiDw6nKTNy0gUOBwjeHeweTg-YRmctMflX9a-q80MD_cN8ldPyuh4toCRSQmN4tv19caSdr9hg9qlZHeGhg_QStyewp2pma8uqrAb6BmeUA7-BpW3h99Qz91NjHXezjeYJb7A9wi_wBBtzjFvcYXhr3WOMexyt8G_fY4B53cY8V7vFd3OMG98_R6Xg02_tsVa1HLO5Qr7AkpYnr2dznlLgyCagfCOFFsPixpScCYXuc-DEVsEdyEgd-lHDuEB5LX3IffP4XaCObZ_IVwt4ul4QkQrUEgNVRzCSjdiAot2VEaeT0kFUbJlyYCjNhrQwBQ4a3DdlD2x3rNQfZPqEqD72HtmpzhhUxLUMlMPFgIc1YD71rdsNUop4PRpmcl_ozjue6AYNTvDQwaE8OFwC-vfP6zyd_gx60N-sW2ijyUr5F60tRblf4_QVxhfMV |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Ovid |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapid+Quantification+of+Gabapentin%2C+Pregabalin%2C+and+Vigabatrin+in+Human+Serum+by+Ultraperformance+Liquid+Chromatography+With+Mass-Spectrometric+Detection&rft.jtitle=Therapeutic+drug+monitoring&rft.au=Chahbouni%2C+Abdel&rft.au=Sinjewel%2C+Arno&rft.au=G+den+Burger%2C+Jeroen+C&rft.au=Vos%2C+Ren%C3%A9+M&rft.date=2013-02-01&rft.pub=Lippincott+Williams+%26+Wilkins+Ovid+Technologies&rft.issn=0163-4356&rft.eissn=1536-3694&rft.volume=35&rft.issue=1&rft.spage=48&rft_id=info:doi/10.1097%2FFTD.0b013e31827788c0&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=2868318601 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-4356&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-4356&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-4356&client=summon |